捆绑SM社区

Genes associated with infantile forms of schizophrenia identified

Discovery will aid diagnosis and development of treatments

Scientists at the Montreal Neurological Institute and Hospital (The Neuro) and 捆绑SM社区 have identified novel genes associated with a specific form of schizophrenia.

Stroke Awareness Month 鈥� June, 2018

Award-winning unit will add 10 new beds this year

听

Stroke is the third-leading cause of death in Canada. Each year, some 14,000 Canadians die as a result of a stroke.

June is Stroke Awareness Month, a time to spread awareness of the causes and effects of stroke as well as its treatment.

June is ALS Month

A look at the latest ALS research and clinical care at The Neuro

Amyotrophic lateral sclerosis (ALS) is a terrible disease with no known cure. Research at The Montreal Neurological Institute and Hospital (The Neuro) is uncovering data that could help find effective treatments for ALS.听

June is Brain Injury Awareness Month

The Neuro鈥檚 Alain Ptito is focussing public attention on the danger of concussion

By Victor Swoboda

On the day that you read this, more than 400 Canadians on average will suffer a concussion or some other brain injury.

$1M donation to support autism research powered by open science

Djavad Mowafaghian Foundation shares The Neuro鈥檚 open science vision to accelerate drug discovery and find new and effective treatments for autism spectrum disorders

Philanthropy and government unite to advance research and patient care and to establish leading edge facilities and technologies at The Neuro

Today, May 23, 2018, The Montreal Neurological Institute and Hospital (The Neuro) gratefully acknowledged significant government funding and unveiled the Thinking Ahead Campaign (2007-2013) donor wall as a tribute and thank you to the many people who helped transform The Neuro鈥檚 ability to deliver cutting-edge research and clinical care.

CENTECH鈥檚 Propulsion Program will help Innodem Neurosciences succeed globally

CENTECH, a Montreal-based technology incubator, announced earlier that it has selected a company founded by Dr. Etienne de Villers-Sidani for its Propulsion Program, which helps the most innovative start-ups move from the initial development phase to commercializing their products and services on the international market. Dr.

MS Month 2018: Care and research at The Neuro

May is Multiple Sclerosis (MS) Month. Laboratory and clinical studies related to MS involve about 50 members of The Neuro鈥檚 staff. They study the disease in all its aspects and at every stage with the help of the most advanced brain imaging technology and the latest cell biology techniques.

Early HIV treatment key to avoiding brain atrophy

While the human immunodeficiency virus (HIV) has largely dropped from news headlines since the 1990s, at the end of 2016 there were 36.7 million people living with the infection, and of those only 53 per cent had access to treatment. A new study underscores the neurological consequences of exposure to HIV without antiretroviral therapy.

The Neuro signs agreement with Chinese and Cuban institutes

On April 20, 2018, Canadian, Chinese and Cuban neuroscience institutes strengthened an existing partnership with the signing of a memorandum of understanding in Chengdu, China.

The Neuro marks Parkinson鈥檚 Awareness Month

April is Parkinson鈥檚 Awareness Month, a time to give special attention to a disease that affects approximately 100,000 Canadians. As a centre for both research and clinical treatment of Parkinson鈥檚 disease (PD), the Montreal Neurological Institute and Hospital (The Neuro) offers many specialized services and opportunities to participate in research to PD patients.

Trenholm receives HFSPO career development award

Stuart Trenholm, who joined The Neuro in 2017 as an assistant professor, has received a Career Development Award from The International Human Frontier Science Program Organization (HFSPO), the only Canadian researcher to receive one this year. 听

Epilepsy research and care at The Neuro

The Neuro is recognized worldwide as a leader in epilepsy research and treatment. From the beginning, Neuro founder, Dr. Wilder Penfield, made epilepsy a central focus. He and his colleagues developed a surgical treatment for epilepsy patients known as the 鈥淢ontreal Procedure,鈥� which today is in use throughout the world.

Cancer probe chosen for top science discovery

Qu茅bec Science magazine鈥檚 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner.

Neuro XXceptional: Celebrating exceptional women

听